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Abstract:    The  antibacterial  activity  of  various  solvent 
fractions  of  Balaguduchi,  Dhanadanayanadi  and 
Dasamoolabala  was  studied  against  the  isolated  nosocomial 
pathogens  by  in  vitro  method.  The  methanol,  acetone, 
choloroform,  acetone fractions  of  test  drugs  and  decoctions 
exhibited different levels of antibacterial activity from low to 
very high level against the gram positive and gram –negative 
bacteria.  The zone of inhibition of each fraction of drugs was 
compared  with  the  standard  antibiotics  Penicillin  and 
Streptomycin.  The present study proves and explains the ability 
and potency of the extracts of Balaguduchi, Dhanadanayanadi 
and  Dasamoolabala  as  a  preventive  measure  of  secondary 
infections by bacteria in the hospitalixe patients.  Even though, 
these  medicines  are  prescribed  in  ayurveda  for  the  different 
clinical  indications,  the  possible  secondary  activity  is  also 
proved through this study. 
Key  words:  Nosocomial  pathogens,  antibacterial  activity, 
Balaguduchi, Dhanadanayanadi, Dasamoolabala.   
 
INTRODUCTION 
The    search  for  drugs  and  methods  of 
identifying  remedies  for  a  number  of 
aliments is as old as humanity. The various 
measures  and  devices,  Practices  and 
methods  varied  with  the  passage  of  time.  
Ayurveda, the most ancient of the sciences 
is not just a compendium of diseases but a 
system  of  medicine  that  has  enunciated 
principles  relating  to  promotion  and 
maintenance of health. 
Nosocomial  infections  are  defined  as 
infections acquired during or as a result of 
hospitalization. Generally, a patient who has 
been in the hospital for less than 48 h and 
develops an infection is considered to have 
been  incubating  the  infection  prior  to 
hospital  admission.    Most  infections 
manifested  after  48h  are  considered  to  be 
nosocomial
1.  Patients  may  still  develop  a 
nosocomial infection after hospital discharge  
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if the organism presumably was acquired in 
the  hospital.    Based  on  the  sites  of 
nosocomial infections, it can  be generally 
classified  as,  Urinary  tact  infections, 
surgical  sit  infections,  Respiratory  tract 
inflections,  Blood  stream  infections,  Skin 
infections,  gastrointestinal tract infections, 
Central  nervous  system  infections  etc
2. 
Surgical wound infection developing in the 
weeks after hospital discharge is an example 
of  nosocomial  infection2.    Nosocomial 
infections  contribute  significantly  to 
morbidity and even mortality, as well as to 
excess costs, for hospitalized patients
3. It is 
estimated  that  3  to  5  percent  of  patients 
admitted  to  an  acute  care  hospital  in  the 
United states acquire a new infection, which 
accounts  for  about  2  million  nosocomial 
infections  per  year  and  an  annual  cost  in 
excess of 2 billion dollars
4. Some estimate 
that  the  cases  of  death  double  in  patients 
who  develop  a  nosocomial  infection, 
although clearly such factors as underlying 
disease and severity of illness also play an 
important  role
5.  About  30  %  of  patient 
admitted to  hospitals  and nursing home in 
the country acquire nosocomial infections as 
against  an  impressive  5%  in  the  west, 
according to Members of Hospital Infection 
Society  (HIS),  India.    This  alarming 
situation is attributed to hospitals reluctance 
to  invest  in  infection  control,  lack  of 
awareness and improper waste management.  
In  a  few  instances,  nosocomial  infections 
lead to septicemia having a mortality rate of 
80%
6.  Worldwide,  around  14  lakh  people 
suffer from hospital-acquired infections
7. 
Resistance  to  antimicrobial  agents  such  as 
antibiotics is emerging in a wide variety of 
organisms  and  multiple  drug  resistant 
organisms  pose  serious  threat  to  the 
treatment  of  infectious  diseases  8,9,10. 
Plants  are  known  to  possess  antibacterial 
activity; several of them have been used in 
traditional  medicine  to  treat  wound 
infections. 
The  Present  study  aims  to  evaluate  the 
ability and efficacy of antimicrobial activity 
of  various  solvent  fractions  of  three  basic 
Ayurvedic  drugs/formulations,  Balagulichi, 
Dhanadanayanadhi  and  Dasamoolabala  on 
the isolated nosocomial pathogens. 
MATERIALS AND METHODS 
MATERIALS REQUIRED: 
EQUIPMENTS:  Soxhlet  Extraction  Unit, 
Laminar  Flow, Autoclave,  Incubator,  Zone 
Reader  
MEDIA  :  Nutrient  broth,  Nutrient  Agar, 
Blood  Agar,  Mueller  Hinton  Agar  were 
purchased from Hi-Media, India. 
SOLVENTS & CHEMICALS: Methanol, 
Acetone, Petroleum ether, Chloroform were 
purchased from Merck, India.  All are AR 
grade.  Dimethyl  formamide-AR  grade-
Merck, Whatmann No.1. Filter Paper Discs. 
Paper  Discs.  Penicillin  and  Ciprofloxacin 
from local market. 
DRUGS:  Balagulichi,  Dhanadanayanadhi, 
and Dasamoolabala were received from the 
Pharmacy  Division  of  Central  Research 
Institute  (Ayurveda),  Cheruthuruthy  Kerala 
these  drugs  were  prepared  as  per  the 
Ayurvedic formulary of India 11,12. 
METHODOLOGY  
SOLVENT EXTRACTION:  
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The  25  gm  of  dry  material  of  drugs 
Balagulichi,  Dhanadanayanadhi,  and 
Dasamoolabala  was  weighted  and  packed 
individually  in  the  cellulose  thimble  for 
solvent  extraction in  the Soxhlet unit.  The 
four  different  solvents  of  various  polarity 
like methanol, Petroleum ether, Chloroform 
and  Acetone  were  used  for  the  extraction.  
Each  solvent  extraction  was  carried  out 
individually  using  freshly  medicine  each 
time.  This extraction procedure was carried 
out for 12 hours continuously. At the end of 
the  extraction  procedure,  the  solvent  was 
removed by distillation and the Solvent-free 
dried  extract  was  dissolved  in  Dimethyl 
formamide and it used for the present study 
at the concentration of 10 mg/ml. the water 
extract  decoction  was  prepared  as  per 
Ayurvedic formulary of India. The  filtered 
portion  of  decoction  was  used  for  the 
present study. 
PREPARATION OF MEDIA: 
The media plates were prepared ascetically 
as per the instruction given by the suppliers 
(Hi-Media). The solidified plated were ready 
for inoculation and excess plates were stored 
in 40C for further use. 
ISOLATION OF BACTERIA: 
The  pathogenic  bacterial  strains  of  E.Coli, 
Klebsiella  pneumonia,  Pseudomonas 
aeruginosa and Staphylococcus aureus, were 
isolated from the biological samples (urine, 
throat swab, nasal discharges, sputum) of IP 
patients,  bystanders,  coworkers  of  CRIA, 
Cheruthuruthy. The selective mediums were 
used  for  specific  culturing  of  E.coli, 
Pseudomonas  aeruginosa,  Klebsiella 
pneumonia,  and  Staphylococcus  aureus.  
The  isolates  were  confirmed  by  specific 
biochemical tests.  The stock cultures were 
prepared  and  stored  in  Nutrient-Agar 
medium at 40C. 
INOCULATION OF TEST PLATES: 
Optimally, within 15 minutes after adjusting 
the turbidity of the inoculums suspension to 
contain  approximately  1-2x10
8  CFU/ml,  a 
sterile  cotton  swab  was  dipped  into  the 
adjusted  suspension  and  pressed  firmly  on 
the inside wall of the tube above the fluid 
level to remove excess inoculums from the 
swab. 
The  dried  surface  of  Mueller-Hinton  agar 
plate was inoculated by streaking the swab 
over  the  entire  sterile  agar  surface.    The 
procedure  was  repeated  by  streaking  two 
more times, rotating the plate approximately 
60
o each time to ensure an even distribution 
of inoculum and as a final step, the rim of 
the agar was swabbed. 
PREPARATION OF DISCS: 
The  circular  discs  of  6mm  diameter  were 
prepared from whatman No.1. filter paper, 
sterilized and used.  The discs were found to 
have 251 holding capacity. 
DISC DIFFUSION METHOD: 
The  Kirby-Bauer’s  Disc  Diffusion  method 
was used in this present study to determine 
the  antimicrobial  susceptibility  of  test 
samples.    The  national  Committee  for 
Clinical  Laboratory  standards  (NCCLS)  is 
recommending  the  Kirby-Bauer’s  disc 
diffusion  method  for  performing 
antimicrobial  susceptibility  testing  13,14.  
The clear labeling of samples were marked 
on the plate.  The plates were then inverted 
and incubated at 370C for 24 hours. 
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ZONE OF INHIBITION: 
The  zone  of  inhibition  was  obtained  by 
measuring the clear zone around each disc 
by Zone Reader.  The value were noted in 
millimeter.  The  statistical  analysis  was 
carried out. 
RESULTS AND DISCUSSION 
The overall study shows that various solvent 
fractions  of  the  Ayurvedic  formulations  of 
Balaguduchi,  Dhanadanayanadi  and 
Dasamoolabala  do  have  the  potential 
antimicrobial activity against the nosocomial 
pathogens.  Some of the solvent fractions do 
not have activity against Gram-positive but 
on Gramnegative and vice-versa. 
The present study reveals that the Ayurvedic 
formulation  have  the  specificity  towards 
types  and  species  of  organisms  and  the 
efficacy was comparable one with standard 
antibiotics. 
EXTRACTION OF DRUGS: 
The extract efficiency of polar and non-polar 
solvents on each drug was determined and 
unextractable  portion  was  calculated.    The 
details have been mentioned in table1. 
BALAGULICHI: 
The methanol fraction of Balaguduchi was 
high  in  quantity  (10.3%)  among  the  other 
solvent  fractions.    The  polar  solvents 
brought  the  highest  quantity  of  extraction 
(Table 1). 
The antibacterial activity of each fraction of 
Balaguduchi has been presented in Table 2.  
Methanolic fraction of drug showed highest 
activity  on  Gram-positive  bacteria 
Staphylococcus (14.1±0.76) and the lowest 
activity  was  on  Klebsiella.    The  acetone 
fraction has nil activity on Klebsiella but on 
other  microorganisms.    The  chloroform 
extract showed zone of inhibition 12.0±1.15 
for  E.coli  followed  by  Pseudomonas 
(11.0±0.57)  and  Staphylococcus  aureus 
(10.0 ±1.0). Petroleum ether fraction of drug 
does  not  have  activity  on  Klebsiella  but 
highest  zone  of  inhibition  on 
Staphylococcus (Table 2). The decoction of 
the  drug  was  observed  to  be  effective  in 
E.Coli and Staphylococcus but ineffective in 
inhibiting  the  growth  of  Klebsiella  and 
Pseudomonas.  The antimicrobial potency of 
the  various  fractions  of  the  drug  was 
compared  with  other  experimental  study 
dugs Dhanadanayanadi and Dasamoolabala. 
DASAMOOLABALA: 
The overall extractable portion was very low 
in the drug Dasamoolabala.  The methanol 
and acetone fraction found to be 4.31% and 
1.21%  respectively.    The  chloroform 
fraction  was  0.78%  and  0.62%  for 
Petroleum ether. 
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Extraction percentage of Balaguduchi, Dhanadanayanadi and Dasamoolabala 
 
S.No.  Name of 
Solvent 
Extract obtained (in Percentage) 
BALAGUDUCHI  DHANADHANAYANADI  DASAMOOLABALA 
1.  Methanol  10.3  15.84  4.31 
2.  Acetone  7.42  11.2  1.21 
3.  Chloroform  7.0  4.48  0.78 
4.  Petroleum Ether  4.24  3.25  0.62 
5.  Unextractable 
Portion 
71.04  65.23  93.06 
 
Table 1. The details of extraction efficiency (in percentage) 
of Balaguduchi, Dhanadhanayanadi and Dasamoolabala using Solvent Extraction Method. 
 
 
Antimicrobial activity of Balaguduchi 
S.No.  Name of 
Sample 
Zone of Inhibition (in mm) on microbes isolated from Biological Samples 
E.coli  Klebsiella  Pseudomonas  Staphylococcus aureus 
1.  Methanol 
Extract 
9.8 ± 1.04  9.1±1.25  10.1±1.04  14.4±0.76 
2.  Acetone 
Extract 
10.8±1.6  NIL  8.8±0.76  11.1±1.0 
3.  Chloroform 
Extract 
12.0±1.15  NIL  11.6±0.57  10.0±1.0 
4.  Petroleum 
Ether Extract 
11.8±1.04  NIL  10.1±1.04  16.3±1.52 
5.  Decoction  10.1±1.08  NIL  NIL  8.3±0.57 
6.  Penicillin  Not Used  Not Used  Not Used  20.0±0.35 
7.  Ciprofloxacin  33.0±1.06  35.0±0.75  41.0±0.70  Not Used 
 
Table.2 Antimicrobial activity of different solvent extractions of BALAGUDUCHI 
at 250 µg/disc concentration and comparison with standard antibiotics 
at 25 µg/disc concentration level. (Values are expressed as MEAN±SD) 
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Antimicrobial activity of Dhanadanayanadi 
S.No.  Name of 
Sample 
Zone of Inhibition (in mm) on microbes isolated from Biological 
Samples 
E.coli  Klebsiella  Pseudomonas  Staphylococcus 
aureus 
1.  Methanol 
Extract 
NIL  NIL  11.1±0.76  11.3±0.75 
2.  Acetone 
Extract 
NIL  NIL  9.1±1.25  14.5±0.5 
3.  Chloroform 
Extract 
11.5±0.50  NIL  10.7±1.04  11.5±0.76 
4.  Petroleum 
Ether Extract 
NIL  NIL  12.1±1.04  9.5±0.86 
5.  Decoction  12.1±1.05  13.8±1.04  8.8±0.76  10.5±0.5 
6.  Penicillin  Not Used  Not Used  Not Used  20.0±0.35 
7.  Ciprofloxacin  33.0±1.06  35.0±0.75  41.0±0.70  Not Used 
 
Table.3.Antimicrobial activity of different solvent extractions of DHANADANAYANADI at 
250 µg/disc concentration and comparison with standard antibiotics at  
25 µg/disc concentration level. (Values are expressed as MEAN±SD) 
 
Antimicrobial activity of Dasamoolabala 
S.No.  Name of 
Sample 
Zone of Inhibition (in mm) on microbes isolated from 
Biological Samples 
E.coli  Klebsiella 
Pneumoniae 
Pseudomonas 
aeruginosa 
Staphylococcus 
aureus 
1.  Methanol 
Extract 
11.1±1.04  9.8±0.76  11.8±0.76  10.0±1.0 
2.  Acetone Extract  11.3±0.57  11.5±0.5  8.6±0.57  11.0±1.20 
3.  Chloroform 
Extract 
9.8±0.76  13.8±0.76  9.1±1.25  10.3±1.04 
4.  Petroleum 
Ether Extract 
14.0±1.0  8.8±0.76  10.8±0.76  NIL   
5.  Decoction  9.8±0.76  9.1±0.06  NIL  NIL 
6.  Penicillin  Not Used  Not Used  Not Used  20.0±0.35 
7.  Ciprofloxacin  33.0±1.06  35.0±0.75  41.0±0.70  Not Used 
 
Table.3.Antimicrobial activity of different solvent extractions of DASAMOOLABALA 
at 250 µg/disc concentration and comparison with standard antibiotics  
at 25 µg/disc concentration level. (Values are expressed as MEAN±SD) 
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The  methanolic  fraction  of  Dasamoolabala 
showed  good  antibacterial  activity  against 
E.coli  and  Pseudomonas  and  minimal 
activity  on  Klebsiella  and  Staphylococcus.  
Both  fractions  of  acetone  and  chloroform 
exhibited  antibacterial  activity  on  all  the 
Gram  positive  and  Gram  negative  study 
microorganisms.  The zone of inhibition was 
higher  in  Klebsiella  against  acetone  and 
chloroform.    Decoction  of  drug  does  no 
inhibit  the  growth  of  Pseudomonas  and 
Staphylococcus but on E.coli (9.8±0.76) and 
Klebsiella  (9.1±1.06).    the  standard 
antibiotics Penicillin and Ciprofloxacin were 
used  in  the  study  as  a  control  at  the 
concentration of 25µg/disc.  Penicillin was 
observed to have zone of inhibition 20.0 ± 
0.55  on  Staphylococcus  and  Ciprofloxacin 
exhibited  33.0  ±  1.06,  35.0±0.75  and 
41.0±0.70  on  E.Coli,  Klebsiella  and 
Pseudomonas respectively. 
The  experiment  exhibited  the  antibacterial 
property of the ayurvedic drugs/formulations 
Balaguduchi, Dhanadanayanadi were having 
nearly 30 to 40% of extractable portion and 
in  this  60  to  75%  were  by  polar  solvents.  
The  carbohydrates,  proteins,  pectins,  cell 
wall  molecules,  lignans  might  have  come 
with  the  polar  solvents  like  methanol  and 
acetone.    The  fatty  acids  and  lipids  might 
have come with the non-polar solvents and 
so the quantity was also very low comparing 
with earlier.  But both of the extracts were 
found  to  have  significant  antibacterial 
activity.  The novelty of the study is that the 
experiment  proves  and  explains  the  ability 
and potency of the extracts of Balaguduchi, 
Dhanadanayanadi  and  Dasamoolabala  as  a 
preventive  measure  of  the  seconday 
infections by the bacteria in the hospitalized 
patients for the treatment of various chronic 
diseases (primary disease) such as paralysis, 
rheumatoid  arthritis  etc.    Since  the 
secondary  infections  are  mainly  associated 
with  the  environment,  food  habits  and 
mostly air-borne diseases, these extracts can 
be used as  a preventive medicine, such as 
vaccines in modern medicine, especially to 
the  patients,  bystanders,  other  staffs  those 
who are associated with the hospital work .  
The  study  made  to  understand  that  even 
though the decoction of some drugs does not 
have the antibacterial property against some 
pathogens,  but  fractionation  of  the  same 
drug  by  suitable  solvent  may  have  the 
property.    Further  purification  of  these 
extracts  through  the  various  advanced 
scientific  methodologies,  may  bring  out 
variety of novel molecules that are present 
in  the  valuable  Ayurvedic  drugs,  and 
identification  of  these  molecules  will  be 
helpful to use as biomarkers of these drugs.  
Since  these  cruds  extract  itself,  has  the 
comparable  antibacterial  activity  with  the 
Penicillin  and  Ciprofloxacin,  the  further 
purification and fractionation of these crude 
extracts,  certainly  will  bring  the  multifold 
functional ability – molecules that will have 
greater biopotency than the drugs presently 
existing in the modern pharmacopoeia.  So 
the  present  study  revealed  the  new 
functional  properties  of  the  Balaguduchi, 
Dhanadanayanadi and Dasamoolabala drugs 
with  reference  to  preventive  measure  of 
nosocomial infections.  The further research 
is  highly  essential  to  identify  and 
characterize  the  various  functional 
molecules of these drugs and their potency 
also, for the welfare of human beings. 
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